成都哪个医院看老烂腿-【成都川蜀血管病医院】,成都川蜀血管病医院,成都治疗血管瘤医院好,成都鲜红斑痣科医院有几家,成都腿部淋巴水肿,成都治疗血管畸形看什么科,成都海绵状血管瘤哪里做手术比较好,成都私立精索静脉曲张医院
成都哪个医院看老烂腿成都下肢动脉硬化好的医院,成都海绵状血管瘤哪个医院治比较好,成都小腿静脉血栓看哪个科,成都治疗前列腺肥大得花多少钱,成都小腿静脉曲张做手术,成都脉管畸形哪家医院专业,成都中医治血管瘤
SAN DIEGO (CNS) - UC San Diego announced Monday a million gift from the John and Mary Tu Foundation, designated to help increase the number of people tested for COVID-19, as well as develop new ways to track and treat the virus.The award supports the clinical research activities of UCSD translational research virologist Dr. Davey Smith, who is "advancing new diagnostics, therapies and ways to monitor the spread of the virus," according to a university statement."What we are trying to do is save lives," John Tu said of the gift to create the John and Mary Tu Foundation COVID-19 Response Fund. "It's very simple: with this research, Dr. Smith is working on behalf of everybody, to save us, to save the world."At the onset of the pandemic, Smith and his team began to investigate methods that would increase the efficiency of testing as well as understand the disease process -- how the virus mutates and spreads within a population. Through sequencing the virus, he is able to track the disease as it spreads into vulnerable populations, which informs the best means for contact tracing.Smith is also leading clinical trials to test new drugs for treatment of COVID-19 for those who have moderately severe cases."At this critical time during the COVID-19 pandemic, the generosity of the John and Mary Tu Foundation has an immediate positive impact on our efforts," said UCSD Chancellor Pradeep K. Khosla. "Their support allows experts like Davey Smith to quickly mobilize to mitigate the spread of the virus and develop treatments for those affected."Smith said the gift was important, as he and his team had limited resources, which would have frozen their progress."The foundation saw that time was of the essence in this pandemic and that science was going to get us out of it," he said. "Now we are conducting a number of clinical trials, including those for vaccines, and have found new drugs that will likely move to treatments soon."As chief of UC San Diego's Division of Infectious Diseases and Global Public Health and co-director of the San Diego Center for AIDS Research, Smith and his team are positioned to rapidly respond to the spread of pandemics like COVID-19."It's not a matter of if a pandemic can happen, but when," Smith said. "We need to bolster science, technology and capabilities to prepare for pandemics." 2347
SAN DIEGO (KGTV) — A new cancer treatment is now available at the Scripps MD Anderson Cancer Center.This week 31-year-old William Apodaca became the first patient in San Diego County to receive the unique form of targeted cancer therapy. Apodaca was diagnosed with a rare form of cancer three years ago when doctors found neuroendocrine tumors in his pancreas.Neuroendocrine tumors are formed in hormone-making cells. They can grow in spots like your pancreas, stomach, and intestines. “It's a rare tumor that patients can live decades with and the hope is to improve quality of life by minimizing their need for more toxic chronic therapies,” said Dr. Marin Xavier, a Medical Oncologist at Scripps MD Anderson Cancer Center. RELATED: FDA approves two cancer treatments after expedited reviews“It was just devastating,” remembers Apodaca, who is also a nurse. After chemotherapy and other cancer-fighting therapies, Apodaca was finally able to try the new treatment, Lutathera, after it was FDA-approved earlier this year. Lutathera uses radioactively charged proteins to seek and attack cancer cells from the inside out. It is administered in four doses, which are given approximately every other month until they are finished. Apodaca had been traveling to Los Angeles for the treatments but was able to complete his final one in San Diego. He now has more energy and looks forward to going back to work, traveling, and getting married.“This medication is pretty much giving me a second chance at life,” said Apodaca. “Picking up the pieces of where my life was.”The drug works for two to five years, depending on how aggressive the tumors are. Patients who respond well can get retreated.Fifteen local patients have already signed up to get the new treatment and more are expected to come from other cities. It is covered by Medicare and other private insurers. 1874
SAN DIEGO (KGTV) - 10News sat down exclusively with Father Joe Carroll to talk about his legacy and fight against homelessness.He got involved with the homeless in San Diego in 1982. "The bishop called me in his office told me, the next day he's going to appoint me head of St. Vincent de Paul and my job was to build a shelter."Immediately assigned as the guy to find a solution to the problem, "When I first started, I'd be writing letters, 'please help me, please help me' and I'd get stacks back, 'no, no, no'."Despite dealing with rejection and other challenges early on, Father Joe has remained committed to fighting homelessness for decades. As Father Joe says, "the rest is history."He remembers ten years ago when he first recognized the problem of homelessness was growing. "We ignored it and we ignored it and had all these crazy ideas which I still think they have, so, I still think it's not reachable for a few more decades."Father Joe may be retired but he's still involved weekly in the fight against homelessness.As he watches the City of San Diego continue to try and solve the problems, he tells 10News, "housing is not the answer to homelessness."He says, instead, the answer is rehabilitation.After decades of fighting homelessness, Father Joe says the answers come from the individuals themselves, "slowly but surely I learned you had to talk to the homeless first to know what you're doing."While he's more removed from Father Joe's Villages since retirement, he still talks with the homeless community daily."Everyday I get out of here, I shake hands with people who are success stories, and that's what makes me want to do more." 1663
SAN DIEGO (CNS) - Two San Diego City Council members called Wednesday on California Attorney General Xavier Becerra and District Attorney Summer Stephan to investigate San Diego City Attorney Mara Elliott's possible role in an alleged child sexual abuse cover-up at the San Diego Junior Theatre.Council members Scott Sherman and Vivian Moreno sent a jointly written letter to Becerra and Stephan imploring them to investigate allegations made by attorney Matt Valenti that Elliott improperly shared information on the case with then-Junior Theatre Board member Gil Cabrera, who Valenti claims tried to silence the case's whistleblowers."We are writing to respectfully request your respective offices' review and consideration for appropriate action, as the authority to investigate these complaints falls under the jurisdiction of your departments," their letter states. "We believe a timely resolution to the matter is in the best interest of all parties."RELATED: San Diego Junior Theatre teacher convicted of sex with underage studentHilary Nemchik, spokeswoman for the city attorney's office, suggested Valenti's allegations against Elliott are a political attack intended to benefit his lawyer, Cory Briggs, who filed paperwork last month signaling his intent to run against her for city attorney."Mr. Valenti has repackaged allegations he sent to the City Council, the District Attorney and the Attorney General more than two years ago," Nemchik said in an emailed statement. "If any law enforcement agency thinks further review of the Junior Theatre is warranted, we support that decision."In 2017, shortly before former Junior Theatre teacher Eric von Metzke pleaded guilty to unlawful sexual intercourse with a minor, Valenti sent an email summary to Elliott, Becerra and Stephan outlining his claims that Cabrera tampered with the investigation into sexual abuse allegations at the theater.Elliott, Valenti alleges, sent that email to Cabrera, disclosing sensitive information in the process. Elliott has maintained that Valenti made no effort to keep the email summary private or confidential by publishing it online. 2136
SAN DIEGO (KGTV) - A Carlsbad mother believes the social isolation created by the pandemic was one factor in the suicide attempt of her 11-year-old son.A photo shows Jessie, 11, playing tetherball outside her home two Thursdays ago. Hours after the photo was taken, his mother Tara says her son vomited.Soon after, an ambulance was rushing him to the hospital. In her kitchen cupboard was a nearly empty Costco-sized bottle of ibuprofen."It was a 500-pill bottle, and we estimate he took 400 pills," said Tara.At the hospital, Jesse couldn't breathe on his own. His kidneys failed, but doctors were able to save Jesse."It's a miracle, so thankful," said a tearful Tara.The grateful mother is now in search of answers. She talked to her son in the hospital."He said he didn't see that there was much worth living for. He felt like there were too many things stacked up against him," said Tara.Tara believes one of those things has been the social isolation caused by the pandemic. After his family moved, Jesse ended up after a new school in the fall. Tara says his old friends 'ghosted' him."I would encourage him to try to make friends in the neighborhood, and he'd say things like 'Why bother?'" said Tara.Tara thought he was just getting adjusted. Stan Colllins, a suicide prevention specialist with the San Diego County Suicide Prevention Council, says social isolation can cut kids off from the support they lean on to deal with stressors, big and small."We do have data to show there has been an increase in suicidal thoughts among youth," said Collins.In Jesse's case, those thoughts led to action. Tara says she's sharing her family's story in hopes of helping another family."Please lock up your medicaton ... Talk to your kids and see how they're doing. If they need help, make sure you get them help," said Tara.Tara says counselors are helping come up with a plan to best help Jesse.If you or someone you care about is experiencing a suicidal or mental health crisis, call the Access and Crisis Line at (888) 724-7240. 2038